,title,source,link,date
48,Ivonescimab Challenges Tislelizumab Plus Chemo in Advanced ...,Targeted Oncology,news.google.com/articles/CBMiaWh0dHBzOi8vd3d3LnRhcmdldGVkb25jLmNvbS92aWV3L2l2b25lc2NpbWFiLWNoYWxsZW5nZXMtdGlzbGVsaXp1bWFiLXBsdXMtY2hlbW8taW4tYWR2YW5jZWQtZWdmci1ucy1uc2NsY9IBAA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-08-26
0,Selpercatinib Elicits Notable PFS Benefit in RET+ Medullary Thyroid ...,Cancer Network,news.google.com/articles/CBMibGh0dHBzOi8vd3d3LmNhbmNlcm5ldHdvcmsuY29tL3ZpZXcvc2VscGVyY2F0aW5pYi1lbGljaXRzLW5vdGFibGUtcGZzLWJlbmVmaXQtaW4tcmV0LW1lZHVsbGFyeS10aHlyb2lkLWNhbmNlctIBAA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-08-25
71,Will Jakaviâ€™s added evidence for PV cure lead to reimbursement in Korea?,KBR,news.google.com/articles/CBMiPWh0dHBzOi8vd3d3LmtvcmVhYmlvbWVkLmNvbS9uZXdzL2FydGljbGVWaWV3Lmh0bWw_aWR4bm89MjE5MTbSAUBodHRwczovL3d3dy5rb3JlYWJpb21lZC5jb20vbmV3cy9hcnRpY2xlVmlld0FtcC5odG1sP2lkeG5vPTIxOTE2?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-08-25
57,Propulsion of Medullary Thyroid Cancer Clinical Trial Pipeline as ...,Digital Journal,news.google.com/articles/CBMivAFodHRwczovL3d3dy5kaWdpdGFsam91cm5hbC5jb20vcHIvbmV3cy9nZXRuZXdzL3Byb3B1bHNpb24tb2YtbWVkdWxsYXJ5LXRoeXJvaWQtY2FuY2VyLWNsaW5pY2FsLXRyaWFsLXBpcGVsaW5lLWFzLW5vdmVsLWFuZC1leHRlbnNpdmUtMTUtdGhlcmFwaWVzLWxpa2VseS10by1lbnRlci1pbi10aGUtZG9tYWluLWRlbHZlaW5zaWdodNIBAA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-08-25
49,Dara-KRd Quadruplet Makes Waves in Newly Diagnosed Multiple ...,OncLive,news.google.com/articles/CBMiYGh0dHBzOi8vd3d3Lm9uY2xpdmUuY29tL3ZpZXcvZGFyYS1rcmQtcXVhZHJ1cGxldC1tYWtlcy13YXZlcy1pbi1uZXdseS1kaWFnbm9zZWQtbXVsdGlwbGUtbXllbG9tYdIBAA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-08-25
44,Dr Williams on the Mechanism of Action of ADCs in Ovarian Cancer,OncLive,news.google.com/articles/CBMiXWh0dHBzOi8vd3d3Lm9uY2xpdmUuY29tL3ZpZXcvZHItd2lsbGlhbXMtb24tdGhlLW1lY2hhbmlzbS1vZi1hY3Rpb24tb2YtYWRjcy1pbi1vdmFyaWFuLWNhbmNlctIBAA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-08-25
42,FDA Accepts sBLA for Amivantamab/Chemo in EGFR Exon 20+ ...,Cancer Network,news.google.com/articles/CBMiX2h0dHBzOi8vd3d3LmNhbmNlcm5ldHdvcmsuY29tL3ZpZXcvZmRhLWFjY2VwdHMtc2JsYS1mb3ItYW1pdmFudGFtYWItY2hlbW8taW4tZWdmci1leG9uLTIwLW5zY2xj0gEA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-08-25
38,LEAP-010 Trial Discontinued After OS Projection With ...,OncLive,news.google.com/articles/CBMifmh0dHBzOi8vd3d3Lm9uY2xpdmUuY29tL3ZpZXcvbGVhcC0wMTAtdHJpYWwtZGlzY29udGludWVkLWFmdGVyLW9zLXByb2plY3Rpb24td2l0aC1wZW1icm9saXp1bWFiLWxlbnZhdGluaWItaW4tbWV0YXN0YXRpYy1obnNjY9IBAA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-08-25
36,FDA Clears Investigational New Drug Application to Treat ...,Pharmacy Times,news.google.com/articles/CBMieWh0dHBzOi8vd3d3LnBoYXJtYWN5dGltZXMuY29tL3ZpZXcvZmRhLWNsZWFycy1pbnZlc3RpZ2F0aW9uYWwtbmV3LWRydWctYXBwbGljYXRpb24tdG8tdHJlYXQtYW15b3Ryb3BoaWMtbGF0ZXJhbC1zY2xlcm9zaXPSAQA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-08-25
34,Charina Toste Discusses the Educational Obstacles Patients With ...,www.oncnursingnews.com/,news.google.com/articles/CBMibWh0dHBzOi8vd3d3Lm9uY251cnNpbmduZXdzLmNvbS92aWV3L2NoYXJpbmEtdG9zdGUtZGlzY3Vzc2VzLXRoZS1lZHVjYXRpb25hbC1vYnN0YWNsZXMtcGF0aWVudHMtd2l0aC1tcG5zLWZhY2XSAQA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-08-25
